Anti-CD20 Monoclonal Antibody(Rituximab),Starter_specification/price/image

Product Detail
Company Profile

Product Specification

Host	Human
Antigen	CD20
Synonyms	B-lymphocyte antigen CD20, Bp35, Leukocyte surface antigen Leu-16, MS4A1
Accession	P11836
Clone Number	S-SC005
Antibody Type	Recombinant mAb
Isotype	IgG1
Application	Blocking of CD20 signaling Functional assays
Purification	Protein A
Concentration	2 mg/ml
Endotoxin	<2EU/mg
Conjugation	Unconjugated
Physical Appearance	Liquid
Storage Buffer	PBS pH7.4, containing no preservative
Stability & Storage	12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Background

Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.

AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.